fig6

The predictive role of hematologic indicators in locally advanced esophageal squamous cell carcinoma patients receiving neoadjuvant chemoimmunotherapy

Figure 6. Kaplan-Meier survival curves for patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC) stratified by hematologic markers and pathological complete response (pCR). (A) Disease-free survival (DFS) stratified by baseline neutrophil-to-lymphocyte ratio (NLR). (B) DFS stratified by preoperative C-reactive protein-to-albumin ratio (CAR). (C) Overall survival (OS) stratified by baseline NLR. DFS (D) and OS (E) stratified by pCR status.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/